Many things on the pipeline but there are three things that I think will hit next imminently- 4c report with potential company update, r&d refund, or feedback from ath343 work from the European FDA as expected by dr Stamler.
Will be an interesting day for sure but imo I still think .036 and below is still undervalued. Time will tell.
Ann: ATH434 protects brain cells and improves motor function, page-54
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $24.62K | 8.206M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 12356369 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126368541 | 15 |
View Market Depth
| Last trade - 15.42pm 07/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |